CancerLine.org

Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines.


Authors: Maillard M, Eche-Gass A, Ung M, Brice A, Marsili S, Montastruc M, Puisset F, Thomas F
Journal: Cancer chemotherapy and pharmacology
Year: 2021
Volume:
Issue:
Page(s):
Click here to reach fulltext

P A G E S

Home
Journals
Keywords

P A R T N E R S

ScopeMed
BiblioMed
FoodsLine
PhytoMedline
eJManager
Privacy Policy | cancerline.org © 2021